Sysmex Corporation is a Japan-based company principally engaged in the health care business. Along with its subsidiaries, the company is involved in the development, manufacture, sale, and service of clinical laboratory equipment, laboratory test drugs, and products related to laboratory test. The company operates in the domestic market and overseas markets across the Americas, Europe, China, and Asia Pacific.
Sysmex displays a strong position toward environmental sustainability, setting mid and long-term reduction targets across greenhouse gas emissions, water use and waste, as well as developing “eco-friendly” products. Sysmex has set 2020 goals aiming to reduce power consumption of its instruments, materials used in containers and packaging, GHG emissions, and water consumption. The company also utilizes green procurement standards, engaging with and promoting suppliers who weave in environmental considerations into their own practices. Additionally, the company has certified all of its facilities to ISO 9001 and 13485 international quality standards and monitors markets for counterfeit reagents to enforce supply chain quality. In terms of providing greater access to health care, Sysmex has introduced capacity building and donation programs, and, through its acquisition of Partec, the company plans to expand access to affordable products in emerging markets as well. Lastly, Sysmex has developed employee engagement channels, such as training resources and work-life balance programs, which greatly benefit its workforce and drive employee satisfaction.
Sysmex lacks industry best practices in the area of corporate governance; these include the presence of a majority independent board and compensation committee.
Industry: Health Care
To the best of our knowledge the above information is accurate and was obtained from sources we believe to be reliable. Neither the information presented above nor any opinion expressed shall be construed as an offer to sell or a solicitation to buy the security. The views expressed are those of portfolio management as of 12/31/16 and may not reflect current opinions or subsequent events.